Microbiology and Infectious Diseases Research Grants



301 Moved Permanently

Moved Permanently

The document has moved here.




Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
Through this funding opportunity announcement (FOA), NIH wishes to stimulate research in discovery and development of novel, small molecules for their potential use in studying disease treatment...more
Posted On - 2017-07-27


Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03)
The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Small Research Grant...more
Posted On - 2017-07-28


Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by...more
Posted On - 2017-05-12




Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
The purpose of this funding opportunity announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by...more
Posted On - 2017-05-12


HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01)
The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies...more
Posted On - 2017-05-17


HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21)
The purpose of this Funding Opportunity is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of...more
Posted On - 2017-05-17


Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory basic research to develop innovative phylodynamic approaches to identify and prioritize the most rapidly growing...more
Posted On - 2017-06-07




In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to: (a) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug...more
Posted On - 2017-05-12


HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)
The purpose of this Funding Opportunity Announcement (FOA) is to fill scientific gaps needed to (a) inform HBV functional cure strategies by furthering our understanding of unique challenges...more
Posted On - 2017-05-12


Here are the star companies that have succeeded in their corporate social responsibility (CSR) programs. The companies were gathered by Civic 50, a national initiative to survey and rank S&P 500 corporations on how they engage with the communities they serve and utilize best practices in their corporate cultures.




Not for Profit Jobs in Nebraska

  Executive Director Jobs
  Substance Abuse Jobs
  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs